Pancreatic intraepithelial neoplasia is associated with chronic pancreatitis due to serine protease inhibitor kazal type 1 and cystic fibrosis transmembrane conductance regulator mutations

Pancreas

Volumn 39, Issue 6, 2010, Pages 947-948

  Rebours, Vinciane ^a   Couvelard, Anne ^a   Sauvanet, Alain ^a   Hammel, Pascal ^a   Ruszniewski, Philippe ^a   Lévy, Philippe ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN;

ADULT; CASE REPORT; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EPIGASTRIC PAIN; FEMALE; GENE MUTATION; GENETIC CODE; HETEROZYGOTE; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CALCIFICATION; PANCREAS DUCT; PANCREAS TUMOR; PANCREATIC INTRAEPITHELIAL NEOPLASIA; PRIORITY JOURNAL;

CARRIER PROTEINS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PRECANCEROUS CONDITIONS;

EID: 77955224490     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181d78d04     Document Type: Letter

References (11)

1. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med. 1993;328:1433-1437.
2. Rebours V, Boutron-Ruault MC, Schnee M, et al. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol. 2008;103:111-119.
3. Klöppel G, Maillet B. Pseudocysts in chronic pancreatitis: a morphological analysis of 57 resection specimens and 9 autopsy pancreata. Pancreas. 1991;6:266-274.
4. Luttges J, Diederichs A, Menke MA, et al. Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53. Cancer. 2000;88:2495-2504.
5. Rebours V, Couvelard A, Colnot N, et al. Pathology analysis reveals that dysplasic pancreatic ductal lesions are frequent in hereditary pancreatitis. Clin Gastroenterol Hepatol. 2009:16.
6. Drenth JP, te Morsche R, Jansen JB. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut. 2002;50:687-692.
7. Threadgold J, Greenhalf W, Ellis I, et al. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut. 2002;50:675-681.
8. Matsubayashi H, Fukushima N, Sato N, et al. Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer. Cancer Biol Ther. 2003;2:652-655.
9. Cohn JA, Neoptolemos JP, Feng J, et al. Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers. Hum Mutat. 2005;26:303-307.
10. Malats N, Casals T, Porta M, et al. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut. 2001;48:70-74.
11. Teich N, Schulz HU, Witt H, et al. N34S, a pancreatitis associated SPINK1 mutation, is not associated with sporadic pancreatic cancer. Pancreatology. 2003;3:67-68.